Boundless Bio
cancer most common high copy number amplifications frequently occur on when they do it is associated with worse survival | Boundless Bio
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
17 of 51
Related slides by other companies
AstraZeneca
Investor Day
June 2022
her low breast cancer visible but | AstraZeneca
Genelux
Investor Presentation
December 2023
completed phase tested primed heavily patients with platinum resistant or platinum refractory ovarian cancer published in jama oncology link | Genelux
Genelux
Investor Presentation
February 2024
completed phase tested primed heavily patients with platinum resistant or platinum refractory ovarian cancer published in jama oncology link | Genelux
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io